Physician profile
Jonathan C Picard
NPI 1619142841
$6,373.28
in general payments reported to CMS, 2019-2025
40 companies · $1,939 in 2025
The $1,939 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,274 · 2020: $251 · 2021: $39.33 · 2022: $304 · 2023: $639 · 2024: $928 · 2025: $1,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,505.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,612.90 | 2019 | |
| Dendreon Pharmaceuticals LLC | $601.42 | 2024-2025 | Provenge |
| Boston Scientific Corporation | $310.67 | 2019-2025 | Ams 700, Rezum Generator, Axonics |
| Sumitomo Pharma America, INC. | $293.19 | 2023-2025 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $283.60 | 2022-2025 | Keytruda, Zerbaxa, Keytruda Qlex |
| Pfizer INC. | $269.52 | 2020-2025 | |
| Astellas Pharma US INC | $246.80 | 2019-2023 | Veozah |
| Janssen Biotech, INC. | $243.46 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Ferring Pharmaceuticals INC. | $204.46 | 2024-2025 | Adstiladrin |
| Endo USA, INC. | $179.51 | 2024-2025 | Xiaflex, Aveed |
| Abbvie INC. | $178.01 | 2019-2025 | |
| Procept Biorobotics Corporation | $132.18 | 2020 | |
| Teleflex LLC | $129.05 | 2023-2025 | Urolift |
| Coloplast Corp | $127.35 | 2019-2025 | |
| Karl Storz Lithotripsy-America | $119.32 | 2019 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $112.86 | 2022 | |
| Progenics Pharmaceuticals, INC. | $104.26 | 2023-2025 | Pylarify |
| Sun Pharmaceutical Industries INC. | $103.56 | 2023-2025 | Yonsa |
| Laborie Medical Technologies Corp. | $98.72 | 2024-2025 | Eclipse, Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $98.06 | 2019-2024 | Xiaflex |
| Accord Healthcare, INC. | $95.16 | 2025 | |
| Urogen Pharma, INC. | $90.86 | 2025 | |
| 180 Medical, INC. | $87.99 | 2019-2025 | Gentlecath Glide |
| Myriad Genetic Laboratories, INC. | $67.48 | 2024-2025 | Prolaris |
| Blue Earth Diagnostics | $66.37 | 2019-2025 | Posluma |
| Axonics, INC. | $60.10 | 2023 | Axonics |
| Convatec INC. | $58.39 | 2024-2025 | |
| Antares Pharma, INC. | $55.48 | 2022-2024 | Xyosted |
| Tolmar, INC. | $53.43 | 2023-2025 | Eligard, Jatenzo |
| Angiodynamics, INC. | $48.23 | 2024-2025 | Nanoknife |
| Photocure INC | $37.74 | 2019 | |
| Abc Home Medical Supply, INC. | $32.38 | 2022-2025 | |
| Zyla Life Sciences, INC. | $30.17 | 2019-2020 | |
| Calyxo, INC. | $28.23 | 2024 | Cvac Aspiration System |
| Profound Medical Corp. | $23.56 | 2025 | Tulsa-Pro |
| Bayer Healthcare Pharmaceuticals INC. | $22.61 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $21.57 | 2025 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $17.72 | 2022 | |
| Intuitive Surgical, INC. | $15.32 | 2025 | |
| Allergan, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Picard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.